Article
High-Throughput Cervical Cancer Screening Using Intracellular Human Papillomavirus<i>E6</i>and<i>E7</i>mRNA Quantification by Flow Cytometry
1 May 2005
Abstract excerpt
The Papanicolaou (Pap) test, based solely on the morphologic examination of exfoliated cells from the cervix, has reduced deaths due to cervical cancer by 74% in the United States during the past 40 years. During that time, the molecular mechanisms of cervical cancer have largely been elucidated. Taken together, these observations have identified a need for a high-throughput cervical cancer screening assay. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
